Daniel J. Levangie, Director at EXACT SCIENCES CORP (EXAS), sold 5,000 shares at $57.50 ($288K) on 2024-03-01, disclosed to the SEC on 2024-03-04.
Scheduled sale ($288k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PODD | SELL | 2016-03-11 | $524K | — | Filing → |
| PODD | SELL | 2016-03-09 | $477K | — | Filing → |
| LPDX | BUY | 2013-12-06 | $42K | — | Filing → |